CPT code 96574: Photodynamic therapy billing guide for dermatology

Key Takeaways

CPT Code 96574 covers debridement of premalignant hyperkeratotic lesions via targeted curettage or abrasion, followed by photodynamic therapy (PDT) using an externally applied photosensitizing agent and light activation.

Only one PDT code (96567, 96573, or 96574) may be billed per patient per day; 96574 is selected when the physician performs debridement before applying the photosensitizing agent.

HCPCS drug codes J7308 (Levulan Kerastick) or J7345 (Ameluz) must be billed separately alongside CPT 96574 to capture the photosensitizing drug cost.

Pabau’s claims management software helps dermatology practices track code pairings, documentation requirements, and billing workflows for CPT 96574 and related PDT codes.

The official AMA descriptor for CPT 96574 reads: Debridement of premalignant hyperkeratotic lesion(s) (ie, targeted curettage, abrasion) followed with photodynamic therapy by external application of light to destroy premalignant lesions of the skin and adjacent mucosa with application and illumination/activation of photosensitizing drug(s), per day.

This code lives within the dermatology EMR software billing category covering Photodynamic Therapy Procedures (CPT range 96567-96574). It is a per-day code, meaning one unit is billable regardless of how many premalignant lesions are treated in a single session.

What qualifies as debridement under 96574?

The AMA is clear that debridement under 96574 means targeted curettage or abrasion only. Chemical peeling is not an accepted debridement method for this code. Auditors may not consider a chemical peel an acceptable substitute, so practices should avoid using peeling to justify 96574 and should document the specific mechanical technique used.

The physician or qualified healthcare professional must directly apply the photosensitizing agent and initiate light illumination. This requirement distinguishes 96574 from the staff-administered version of PDT captured under 96567.

PDT code comparison chart: 96567, 96573, and 96574

Selecting the right PDT code starts with understanding what distinguishes each one. The three codes in active use are mutually exclusive on the same date of service.

Only one of these three codes applies per patient, per day. The Clinico Oregon PDT Code Information document confirms this restriction, noting that code selection depends on the actual treatment protocol used. Practices that default to a single code without reviewing the session documentation risk under-coding (billing 96567 when 96574 is appropriate) or over-coding (billing 96574 without documented debridement).

For other procedure-specific CPT billing workflows across specialties, see how practices handle IVF CPT codes as a parallel example of multi-code procedure sets with strict documentation requirements.

HCPCS drug codes used with 96574

CPT 96574 covers the procedure. It does not cover the photosensitizing drug. Two HCPCS Level II codes are used alongside 96574 to capture the drug cost, and choosing the correct one depends on which FDA-approved agent was administered.

• J7308 Aminolevulinic acid HCl (ALA), topical application, 20% solution, per unit dose (354 mg) – used when Levulan Kerastick (DUSA Pharmaceuticals) is the photosensitizing agent applied.
• J7345 Aminolevulinic acid HCl (ALA), topical application, 10% gel, per 10 mg – used when Ameluz (Biofrontera) is the photosensitizing agent applied.

Both J7308 and J7345 are billed separately from CPT 96574 on the same claim. The billing entity for the drug code depends on the setting: in a physician office, the physician practice typically bills the drug code, while in a facility setting the drug may be billed by the facility rather than the physician.

Verify with your specific payer contract before submitting, as facility versus professional billing rules vary.

Tracking drug lot numbers, units dispensed, and administration dates is part of complete documentation for J7308 and J7345 claims. Skin clinic software that integrates inventory tracking with billing workflows can reduce transcription errors when pairing drug codes to the corresponding procedure code on each claim.

Levulan vs Ameluz: matching the photosensitizer to the right drug code

J7308 and J7345 are not interchangeable, because the two FDA-approved topical aminolevulinic acid (ALA) products they represent differ in concentration, formulation, incubation, and the light source used to activate them. The agent actually applied dictates both the HCPCS code and the number of units reported, so matching the drug to the code starts with knowing which product was on the tray.

Two billing details flow directly from this comparison. First, the units field differs: J7308 is reported per single-dose 354 mg applicator, while J7345 is reported per 10 mg of gel, so a tube of Ameluz generates a very different unit count than a Levulan Kerastick. Second, short-contact and daylight PDT protocols have become common, and clinical evidence supports comparable actinic keratosis clearance with shorter incubation times. The American Academy of Dermatology guidelines of care for actinic keratosis include photodynamic therapy among recommended field treatments, but the procedure code and the per-day rule stay the same regardless of which incubation protocol the clinician selects.

Recording the exact product, concentration, lot number, and units dispensed at the point of administration keeps the drug claim defensible. Inventory management software that ties each dispensed unit of Levulan or Ameluz to the encounter and claim removes the guesswork when a coder later has to confirm which agent was used and how many units to bill.

Documentation requirements for 96574 claims

A claim for CPT 96574 that arrives without adequate documentation is a denial waiting to happen. The documentation must support every component of the procedure: the presence of premalignant hyperkeratotic lesions, the debridement technique used, the photosensitizing agent applied, and the light activation.

Required elements in the clinical note

• Diagnosis: Documented actinic keratosis or other premalignant lesion with ICD-10-CM code (L57.0 for actinic keratosis is the most common pairing).
• Location and count: Anatomical site(s) treated (face, scalp, or other area) and a general description of lesion burden, even though the code is per day, not per lesion.
• Debridement technique: Explicit documentation of curettage or abrasion performed prior to photosensitizer application. “Pre-treatment curettage of hyperkeratotic lesions prior to ALA application” is the type of language needed.
• Photosensitizing agent: Drug name, concentration, and how it was applied (including incubation time).
• Light source and parameters: Blue light device used, wavelength, dose (joules/cm2), and exposure duration.
• Physician involvement: Note that the physician or qualified healthcare professional directly performed or supervised the drug application and light activation, not just a staff member.

Missing any one of these elements creates an audit vulnerability. Digital intake and consent forms structured specifically for PDT procedures help practices capture all required fields at the point of care, reducing the need to chase documentation after the fact.

ICD-10-CM diagnosis codes that support 96574 claims

The diagnosis code on the claim must be medically consistent with the procedure. The most commonly paired ICD-10-CM codes include:

• L57.0 Actinic keratosis: the primary indication for PDT treatment of premalignant skin lesions.
• L57.8 Other skin changes due to chronic exposure to nonionizing radiation: used for photodermatitis presentations that fall outside the L57.0 descriptor.

Confirm that the diagnosis code submitted is on your payer’s accepted diagnosis list for CPT 96574. Some commercial insurers restrict coverage to specific ICD-10-CM codes, and a mismatch between the procedure code and diagnosis code is a common reason for medical necessity denials.

Reduce claim denials for PDT procedures

Pabau helps dermatology practices track CPT code pairings, documentation checklists, and billing workflows so 96574 claims go out complete the first time.

Book a demo

CPT code 96574 vs 96573: Choosing the right code

The distinction between 96573 and 96574 comes down to one procedural step: debridement. Both codes require physician or qualified healthcare professional direct involvement. Both cover PDT by external application of light. The difference is whether the session included targeted curettage or abrasion of hyperkeratotic lesions before the photosensitizer was applied.

When a practice bills 96574 without documentation of curettage or abrasion, auditors can reclassify the claim to 96573, which may carry a different reimbursement rate. The clinical note must make the debridement step unambiguous.

Practices running high-volume PDT days benefit from structured encounter forms that prompt the documenting clinician to record debridement type before moving to drug application. Before-and-after photo documentation for actinic keratosis cases also supports medical necessity and tracks lesion response across treatment series, which strengthens the overall clinical record for audit purposes.

How many PDT sessions does actinic keratosis treatment need?

Actinic keratosis is a field disease rather than a collection of isolated spots, and a single photodynamic therapy session rarely clears an entire sun-damaged area. Treatment protocols anticipate reassessment and, where lesions persist, repeat treatment of the field after an interval that commonly runs from several weeks to a few months, rather than a one-and-done encounter.

This has a direct coding consequence. Each qualifying session is a separate date of service reported with its own per-day PDT code. There is no add-on code for additional lesions within a session and no multiplier for treating a larger field, so reportable volume scales with documented sessions, not with lesion count. Planning the series up front keeps the treatment plan and the claims aligned, and it gives the patient a clear schedule for the full course of care. Medical scheduling software that books the whole series as a linked set of appointments reduces no-shows in the middle of a treatment course, which is where field clearance most often falls apart.

Aftercare belongs to the same pathway. Topical aminolevulinic acid leaves the skin photosensitive, and patients are instructed to avoid sunlight and bright indoor light for roughly 40 to 48 hours after application to prevent a phototoxic reaction. Delivering those pre- and post-treatment instructions reliably, and documenting that they were given, protects both the patient and the clinical record. Pre- and post-care software can push standardized PDT photosensitivity instructions to each patient automatically at the point of treatment.

Is daylight PDT coded differently from conventional PDT?

Daylight PDT, where the photosensitizer is activated by natural sunlight rather than an in-office blue or red lamp, has grown in popularity because it is generally less painful and keeps patients out of the treatment chair. A common coding question follows: does it get its own code? It does not. There is no separate CPT code specific to daylight PDT. Practices still choose among 96567, 96573, and 96574 using the same two questions that govern lamp-based PDT: was targeted curettage or abrasion performed first, and was the physician or qualified healthcare professional directly involved in applying the agent and initiating light activation?

The wrinkle is the “external application of light” element built into these descriptors. The PDT codes were written around a clinician-controlled light source, and daylight protocols shift the activation step to natural sunlight that the patient is exposed to, sometimes after leaving the office. Because of that, reimbursement for daylight PDT is not addressed uniformly across payers, and some plans scrutinize it more closely than conventional lamp-based PDT. The clinical evidence shows comparable actinic keratosis clearance with significantly less pain, but clinical equivalence does not guarantee a payer treats the two protocols identically for billing. Verify coverage locally before adopting a daylight protocol as a routine billed service.

Whichever protocol a practice runs, the documentation has to make the activation method explicit so the chosen code is defensible. Aesthetic and dermatology teams that offer daylight PDT alongside lamp-based sessions can use medical spa software to standardize the encounter template so the light source, who performed the activation, and the debridement step are all captured the same way at every visit.

Medicare coverage and reimbursement for photodynamic therapy CPT codes

Medicare covers PDT procedures for actinic keratosis when medical necessity criteria are met. Reimbursement rates for CPT Code 96574 are set annually through the Medicare Physician Fee Schedule (MPFS), and payment amounts vary by geographic locality due to geographic practice cost indices (GPCIs).

Key Medicare billing considerations

Prior authorization: Medicare traditionally does not require prior authorization for dermatology-category PDT procedures, but commercial payers often do. Check each payer’s individual policy before scheduling the procedure.

Place of service: The place of service code affects reimbursement. Office-based procedures (POS 11) typically reimburse at the non-facility rate. Facility settings (POS 22 or 23) use the facility rate, which is generally lower for the professional claim.

National Correct Coding Initiative (NCCI) edits: NCCI edits govern which code combinations are and are not allowed together. Billing CPT 96574 and 96567 together on the same date of service for the same patient is not permitted under standard NCCI bundling rules. Only one PDT code applies per day. Modifier -59 (distinct procedural service) does not override this restriction in most circumstances because the codes describe mutually exclusive procedures, not merely overlapping ones.

RVU-based reimbursement: The 2026 fee schedule data for CPT 96574 is published in the Medicare Physician Fee Schedule, which uses CMS data. Actual allowed amounts depend on the MAC jurisdiction and locality. Use the CMS MPFS lookup to verify rates specific to your practice location before projecting revenue.

Efficient claims management software built for dermatology workflows can flag potential NCCI edit conflicts before submission, reducing the volume of avoidable denials on PDT claims.

Medicare’s national coverage policy for actinic keratosis PDT

Separate from the fee schedule, Medicare’s national coverage stance for treating actinic keratosis sits in National Coverage Determination (NCD) 250.4. The policy covers the recognized treatment methods for actinic keratosis, including cryosurgery, curettage, excision, and photodynamic therapy, and it does so without restrictions based on patient or lesion characteristics. In practical terms, Medicare does not condition coverage of PDT on lesion thickness, lesion count, or where on the body the actinic keratosis appears.

What the NCD leaves open is volume. It assigns the local Medicare Administrative Contractor (MAC) the discretion to determine how many treatment visits are reasonable and necessary for a given patient. There is no fixed national cap on the number of PDT sessions, but each session still has to clear the medical-necessity bar, and a long treatment series may draw contractor review. The clinical note for every date of service has to justify why that specific session was needed. Treating medical-necessity documentation as a front-end discipline rather than an appeals problem is the core of a healthy healthcare revenue cycle, where clean claims leave the practice complete the first time.

Commercial payers are a different matter. Many publish their own medical policies for dermatologic PDT that do impose frequency limits or step-therapy requirements, so the absence of a Medicare cap does not mean a commercial plan will reimburse an open-ended series. Confirm each plan’s policy before scheduling the next session. Where a treatment course stretches across months, a patient portal that keeps upcoming PDT appointments, consent forms, and photosensitivity instructions in one place helps patients stay on schedule through the full field-clearance course.

Modifiers and same-day services with CPT 96574

Photodynamic therapy codes are not surgical-package codes. Under the Medicare Physician Fee Schedule they carry an “XXX” global indicator, which means the global-surgery concept does not apply and no bundled pre- or post-operative period is attached to 96574. That distinction shapes how same-day services and modifiers should be handled. Confirm the current indicator in the MPFS lookup, since payment policy fields are updated annually.

Modifier 25: a separately identifiable E/M

When the physician performs a distinct, separately identifiable evaluation and management service on the same day, for example assessing a new or suspicious lesion outside the field being treated, the E/M code carries modifier 25. Routine pre-treatment review of the area being treated is part of the PDT service and does not justify a separate E/M. The note must describe a service that stands on its own. Practices that pair PDT with an office visit should understand the documentation bar for an office or outpatient E/M code before appending modifier 25, because unsupported same-day E/M billing is one of the most audited patterns in dermatology.

Modifiers 59, 51, and units

• Modifier 59 / X{EPSU}: rarely appropriate on PDT claims. Because NCCI treats 96567, 96573, and 96574 as mutually exclusive on the same date, modifier 59 generally will not unbundle two PDT codes reported together.
• Modifier 51 (multiple procedures): 96574 is a per-day code, so it is not subject to per-lesion multiple-procedure reductions within a single session.
• Units: report one unit of 96574 per day regardless of how many premalignant lesions were debrided and treated in that session.

Modifier misuse is a measurable denial driver, and the pattern only becomes visible when you look across claims rather than one at a time. Reporting and analytics tools that break denials down by code and modifier let a practice spot a systematic error, such as a recurring missing modifier 25 or an inappropriate modifier 59, and correct it at the template level instead of appealing claims individually.

Common 96574 billing errors and how to avoid them

Billing errors on PDT claims tend to cluster around a handful of recurring mistakes. Most are preventable with standardized documentation workflows and pre-submission claim edits.

The five most common 96574 billing mistakes

1. Billing 96574 without documented debridement. If the note says “PDT performed” without specifying curettage or abrasion, the claim is vulnerable. Auditors look for the specific debridement technique, not a general reference to pre-treatment preparation.
2. Billing two PDT codes on the same date. Submitting 96567 and 96574 together on the same claim is an NCCI edit conflict. The second code will deny, and if you miss it, you may inadvertently report a bundling violation.
3. Using the wrong HCPCS drug code. J7308 (Levulan) and J7345 (Ameluz) are not interchangeable. Billing J7308 when Ameluz was used is a misrepresentation of the drug administered.
4. Omitting the physician involvement note. Codes 96573 and 96574 require documented physician or QHP direct involvement in both drug application and light activation. If the note describes staff-only administration, the claim should be 96567, not 96574.
5. Treating the code as per-lesion rather than per-day. CPT 96574 is a per-day code. Billing multiple units for multiple lesions in the same session is incorrect and will generate a line-level edit from most payers.

Standardized PDT procedure checklists integrated into your medical forms management workflow can prompt clinical staff to capture each required element before the encounter closes. This is more reliable than relying on individual coders to identify missing documentation after the fact.

For practices managing a high volume of dermatology procedures alongside PDT, a practice management platform with built-in claim scrubbing tools allows coders to review all code pairings against payer-specific rules before transmission, not after denial.

Integrating 96574 into your dermatology billing workflow

PDT billing is more complex than single-code dermatology procedures because it requires coordinating three separate billing elements: the procedure code (96574), the drug code (J7308 or J7345), and the supporting diagnosis code (L57.0 or L57.8). Each must appear on the claim, and each must be supported by documentation.

Practices that treat actinic keratosis with PDT regularly can standardize this workflow. The AAPC Codify CPT lookup provides access to the full code descriptor, related guidelines, and crosswalk data for 96574, which can inform how you build your charge capture template.

A structured approach to PDT encounter documentation also supports prescription management workflows when aminolevulinic acid is prescribed and dispensed in-office. Linking the prescription record to the corresponding encounter and claim reduces the risk of drug code errors and keeps the audit trail complete.

For practices expanding into laser clinic workflows alongside PDT, code set familiarity across both procedure categories is essential: laser and light-based procedures each have their own coding rules and documentation requirements, and conflating them in the billing process is a common source of denials.

Pabau’s claims management software is designed for multi-code dermatology and aesthetics billing workflows. It supports code pairing validation, documentation tracking, and claim status visibility across the full revenue cycle.

Conclusion

CPT Code 96574 is the correct code when a physician performs targeted curettage or abrasion of premalignant hyperkeratotic lesions and then administers photodynamic therapy by external light application in the same session. Getting it right means documenting the debridement technique, pairing the correct HCPCS drug code, and ensuring physician involvement is noted for both drug application and light activation.

Pabau’s automated billing workflows help dermatology teams standardize PDT charge capture, reducing the documentation lapses that turn into denials. To see how Pabau supports dermatology billing from encounter to claim submission, book a demo.

Frequently asked questions